Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: A propensity score-matched analysis

Katsunori Tatsugami, Mototsugu Oya, Koki Kabu, Hideyuki Akaza

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: A propensity score-matched analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences